Antoine C El Khoury

Summary

Affiliation: Merck Research Laboratories
Country: USA

Publications

  1. doi Economic burden of hepatitis C-associated diseases: Europe, Asia Pacific, and the Americas
    Antoine C El Khoury
    Merck and Co Inc, West Point, PA, USA
    J Med Econ 15:887-96. 2012
  2. pmc Burden of community-acquired and nosocomial rotavirus gastroenteritis in the pediatric population of Western Europe: a scoping review
    Isla Ogilvie
    BioMedCom Consultants Inc, Montreal, QC, Canada
    BMC Infect Dis 12:62. 2012
  3. doi Economic burden of hepatitis C-associated diseases in the United States
    A C El Khoury
    Global Health Outcomes, Merck and Co Inc, West Point, PA, USA
    J Viral Hepat 19:153-60. 2012
  4. pmc Projecting the effectiveness of RotaTeq® against rotavirus-related hospitalizations and deaths in six Asian countries
    Antoine C El Khoury
    Merck and Co, Inc, West Point, PA, USA
    Hum Vaccin 7:506-10. 2011
  5. ncbi Projecting the effectiveness of RotaTeq® against rotavirus-related hospitalisations in Brazil
    Antoine Chaouki El Khoury
    Global Health Outcomes, Merck and Company, Inc, West Point, PA, USA
    Mem Inst Oswaldo Cruz 106:541-5. 2011
  6. pmc Perception and management of fever in infants up to six months of age: a survey of US pediatricans
    Antoine C El Khoury
    Merck and Co, Inc, West Point, PA, USA
    BMC Pediatr 10:95. 2010
  7. pmc Burden of rotavirus gastroenteritis in the Middle Eastern and North African pediatric population
    Hanane Khoury
    BioMedCom Consultants Inc, 1405 TransCanada Highway, Suite 310, Montreal, Quebec H9P 2V9, Canada
    BMC Infect Dis 11:9. 2011
  8. doi Cost-effectiveness of a pentavalent human-bovine reassortant rotavirus vaccine for children ≤5 years of age in Taiwan
    Robbin F Itzler
    Merck and Co, Inc, North Wales, PA 19454 2505, USA
    J Med Econ 14:748-58. 2011
  9. doi The burden of untreated hepatitis C virus infection: a US patients' perspective
    Antoine C El Khoury
    Merck and Co, Inc, WP 97 A423, 770 Sumneytown Pike, West Point, PA 19486, USA
    Dig Dis Sci 57:2995-3003. 2012
  10. doi The burden of rotavirus hospitalizations among Medicaid and non-Medicaid children younger than 5 years old
    Liyuan Ma
    Global Outcomes Research, PO Box 4, WP97 243, Merck and Co, Inc, West Point, PA 19486, USA
    Am J Public Health 99:S398-404. 2009

Collaborators

Detail Information

Publications10

  1. doi Economic burden of hepatitis C-associated diseases: Europe, Asia Pacific, and the Americas
    Antoine C El Khoury
    Merck and Co Inc, West Point, PA, USA
    J Med Econ 15:887-96. 2012
    ..The objective of this study was to review published work and determine the direct medical costs for diseases associated with HCV infection globally, with the exception of the US...
  2. pmc Burden of community-acquired and nosocomial rotavirus gastroenteritis in the pediatric population of Western Europe: a scoping review
    Isla Ogilvie
    BioMedCom Consultants Inc, Montreal, QC, Canada
    BMC Infect Dis 12:62. 2012
    ..The objective of this review was to estimate the burden of rotavirus gastroenteritis (RVGE) in the Western European pediatric population...
  3. doi Economic burden of hepatitis C-associated diseases in the United States
    A C El Khoury
    Global Health Outcomes, Merck and Co Inc, West Point, PA, USA
    J Viral Hepat 19:153-60. 2012
    ..Hepatitis C imposes a high economic burden. Most cost analysis is more than 10 years old, and more research is required to update the sequelae costs associated with HCV infection...
  4. pmc Projecting the effectiveness of RotaTeq® against rotavirus-related hospitalizations and deaths in six Asian countries
    Antoine C El Khoury
    Merck and Co, Inc, West Point, PA, USA
    Hum Vaccin 7:506-10. 2011
    ....
  5. ncbi Projecting the effectiveness of RotaTeq® against rotavirus-related hospitalisations in Brazil
    Antoine Chaouki El Khoury
    Global Health Outcomes, Merck and Company, Inc, West Point, PA, USA
    Mem Inst Oswaldo Cruz 106:541-5. 2011
    ..These results suggest that RV5 could substantially prevent RGE-related hospitalisations in Brazil...
  6. pmc Perception and management of fever in infants up to six months of age: a survey of US pediatricans
    Antoine C El Khoury
    Merck and Co, Inc, West Point, PA, USA
    BMC Pediatr 10:95. 2010
    ..A fever is an increase in the body's temperature above normal. This study examined how US pediatricians perceive and manage fever generally versus fever occurring after vaccination in infants up to six months of age...
  7. pmc Burden of rotavirus gastroenteritis in the Middle Eastern and North African pediatric population
    Hanane Khoury
    BioMedCom Consultants Inc, 1405 TransCanada Highway, Suite 310, Montreal, Quebec H9P 2V9, Canada
    BMC Infect Dis 11:9. 2011
    ....
  8. doi Cost-effectiveness of a pentavalent human-bovine reassortant rotavirus vaccine for children ≤5 years of age in Taiwan
    Robbin F Itzler
    Merck and Co, Inc, North Wales, PA 19454 2505, USA
    J Med Econ 14:748-58. 2011
    ..Other cost-effectiveness analyses for rotavirus vaccination in industrialized countries have produced varying results depending on the input parameters assumed...
  9. doi The burden of untreated hepatitis C virus infection: a US patients' perspective
    Antoine C El Khoury
    Merck and Co, Inc, WP 97 A423, 770 Sumneytown Pike, West Point, PA 19486, USA
    Dig Dis Sci 57:2995-3003. 2012
    ..Hepatitis C virus (HCV) infection is widespread and associated with high economic costs and reduced quality of life, but the impact of untreated HCV infection on patient outcome is not well understood...
  10. doi The burden of rotavirus hospitalizations among Medicaid and non-Medicaid children younger than 5 years old
    Liyuan Ma
    Global Outcomes Research, PO Box 4, WP97 243, Merck and Co, Inc, West Point, PA 19486, USA
    Am J Public Health 99:S398-404. 2009
    ..We sought to compare the burden of hospitalizations associated with rotavirus gastroenteritis (RGE) in children younger than 5 years in US Medicaid and non-Medicaid populations in 2000 and 2003...